查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1538233

中和抗體市場報告：2030 年趨勢、預測和競爭分析

Neutralizing Antibody Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

中和抗體的趨勢和預測

預計 2024 年至 2030 年，全球中和抗體市場將以 11.2% 的複合年成長率成長。這個市場的主要驅動力是類風濕性關節炎、多發性硬化症和狼瘡等自體免疫疾病的盛行率不斷上升，感染疾病率的上升，以及與傳統疫苗和藥物相比基於抗體的治療的好處越來越多的人意識到。全球中和抗體市場前景廣闊，醫院/診所、研究所、診斷實驗室和製藥市場充滿機會。

按片段中和抗體

本研究按目標病毒、抗體類型、應用、最終用途和地區對全球中和抗體市場進行了預測。

中和抗體市場洞察

Lucintel 預測，在預測期內，治療藥物仍將是最大的細分市場。

在這個市場中，製藥公司將繼續成為最大的細分市場。

由於重要公司的存在以及全國範圍內一致的醫療保健系統的建立，北美在預測期內將繼續成為最大的地區。

常問問題

Q1.市場成長預測是多少：

A1. 2024年至2030年，全球中和抗體市場預計將以11.2%的複合年成長率成長。

Q2. 影響市場成長的關鍵促進因素是：

A2. 這個市場的主要促進因素是類風濕性關節炎、多發性硬化症和狼瘡等自體免疫疾病的盛行率不斷上升，感染疾病的盛行率不斷上升，與傳統疫苗和藥物相比，人們越來越意識到抗體的好處。

Q3.市場的主要細分市場是：

A3. 全球中和抗體市場前景廣闊，醫院/診所、研究所、診斷實驗室和製藥市場充滿機會。

Q4.市場的主要企業是：

A4. 主要中和抗體公司如下：

  • Regeneron Pharmaceuticals
  • Eli Lilly and Company
  • AstraZeneca
  • GlaxoSmithKline
  • Sanofi
  • Roche
  • Novartis
  • Merck
  • Pfizer
  • Johnson & Johnson

Q5.未來最大的細分市場是什麼？

A5.Lucintel 預計治療藥物在預測期內仍將是其最大的細分市場。

Q6.未來五年預計哪些地區的市場成長最大？

A6. 由於重要公司的存在以及全國範圍內一致的醫療保健系統的建立，預計北美在預測期內仍將是最大的地區。

Q7. 可以客製化報告嗎？

A7。

目錄

第1章執行摘要

第2章全球中和抗體市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球中和抗體市場趨勢（2018-2023）和預測（2024-2030）
  • 按目標病毒分類的全球中和抗體市場
    • SARS-CoV-2
    • HIV
    • 流感
    • 伊波拉
    • 茲卡熱
    • C型肝炎
  • 按抗體類型分類的全球中和抗體市場
    • 單株抗體
    • 多株抗體
  • 全球中和抗體市場（按應用）
    • 治療
    • 診斷
    • 研究與開發
    • 其他
  • 按最終用途分類的全球中和抗體市場
    • 醫院/診所
    • 研究所
    • 診斷實驗室
    • 製藥公司
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球中和抗體市場按地區分類
  • 北美中和抗體市場
  • 歐洲中和抗體市場
  • 亞太中和抗體市場
  • 中和其他地區的抗體市場

第5章 競爭分析

  • 產品系列分析
  • 業務整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
  • 全球中和抗體市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球中和抗體市場產能
    • 全球中和抗體市場的合併、收購和合資企業
    • 認證和許可

第7章主要企業概況

  • Regeneron Pharmaceuticals
  • Eli Lilly and Company
  • AstraZeneca
  • GlaxoSmithKline
  • Sanofi
  • Roche
  • Novartis
  • Merck
  • Pfizer
  • Johnson & Johnson
簡介目錄

Neutralizing Antibody Trends and Forecast

The future of the global neutralizing antibody market looks promising with opportunities in the hospital and clinic, research institute, diagnostic laboratory, and pharmaceutical company markets. The global neutralizing antibody market is expected to grow with a CAGR of 11.2% from 2024 to 2030. The major drivers for this market are growing incidence of autoimmune disorders including rheumatoid arthritis, multiple sclerosis, and lupus, rising prevalence of infectious diseases, and increasing awareness of the benefits of antibody-based therapies compared to traditional vaccines and drugs.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Neutralizing Antibody by Segment

The study includes a forecast for the global neutralizing antibody by target virus, antibody type, application, end use, and region.

Neutralizing Antibody Market by Target Virus [Shipment Analysis by Value from 2018 to 2030]:

  • SARS-CoV-2
  • HIV
  • Influenza
  • Ebola
  • Zika
  • Hepatitis C

Neutralizing Antibody Market by Antibody Type [Shipment Analysis by Value from 2018 to 2030]:

  • Monoclonal Antibodies
  • Polyclonal Antibodies

Neutralizing Antibody Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Therapeutics
  • Diagnostics
  • Research and Development
  • Others

Neutralizing Antibody Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals and Clinics
  • Research Institutes
  • Diagnostic Laboratories
  • Pharmaceutical Companies
  • Others

Neutralizing Antibody Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Neutralizing Antibody Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies neutralizing antibody companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the neutralizing antibody companies profiled in this report include-

  • Regeneron Pharmaceuticals
  • Eli Lilly and Company
  • AstraZeneca
  • GlaxoSmithKline
  • Sanofi
  • Roche
  • Novartis
  • Merck
  • Pfizer
  • Johnson & Johnson

Neutralizing Antibody Market Insights

Lucintel forecasts that therapeutic will remain the largest segment over the forecast period.

Within this market, pharmaceutical company will remain the largest segment.

North America will remain the largest region over the forecast period due to the existence of important vital firms and a consistent healthcare system across the country.

Features of the Global Neutralizing Antibody Market

Market Size Estimates: Neutralizing antibody market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Neutralizing antibody market size by target virus, antibody type, application, end use, and region in terms of value ($B).

Regional Analysis: Neutralizing antibody market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different target virus, antibody type, application, end use, and regions for the neutralizing antibody market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the neutralizing antibody market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for neutralizing antibody market?

Answer: The global neutralizing antibody market is expected to grow with a CAGR of 11.2% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the neutralizing antibody market?

Answer: The major drivers for this market are growing incidence of autoimmune disorders including rheumatoid arthritis, multiple sclerosis, and lupus, rising prevalence of infectious diseases, and increasing awareness of the benefits of antibody-based therapies compared to traditional vaccines and drugs.

Q3. What are the major segments for neutralizing antibody market?

Answer: The future of the global neutralizing antibody market looks promising with opportunities in the hospital and clinic, research institute, diagnostic laboratory, and pharmaceutical company markets.

Q4. Who are the key neutralizing antibody market companies?

Answer: Some of the key neutralizing antibody companies are as follows:

  • Regeneron Pharmaceuticals
  • Eli Lilly and Company
  • AstraZeneca
  • GlaxoSmithKline
  • Sanofi
  • Roche
  • Novartis
  • Merck
  • Pfizer
  • Johnson & Johnson

Q5. Which neutralizing antibody market segment will be the largest in future?

Answer: Lucintel forecasts that therapeutic will remain the largest segment over the forecast period.

Q6. In neutralizing antibody market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to the existence of important vital firms and a consistent healthcare system across the country.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the neutralizing antibody market by target virus (SARS-CoV-2, HIV, influenza, Ebola, zika, and hepatitis C), antibody type (monoclonal antibodies and polyclonal antibodies), application (therapeutics, diagnostics, research and development, and others), end use (hospitals and clinics, research institutes, diagnostic laboratories, pharmaceutical companies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Neutralizing Antibody Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Neutralizing Antibody Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Neutralizing Antibody Market by Target Virus
    • 3.3.1: SARS-CoV-2
    • 3.3.2: HIV
    • 3.3.3: Influenza
    • 3.3.4: Ebola
    • 3.3.5: Zika
    • 3.3.6: Hepatitis C
  • 3.4: Global Neutralizing Antibody Market by Antibody Type
    • 3.4.1: Monoclonal Antibodies
    • 3.4.2: Polyclonal Antibodies
  • 3.5: Global Neutralizing Antibody Market by Application
    • 3.5.1: Therapeutics
    • 3.5.2: Diagnostics
    • 3.5.3: Research and Development
    • 3.5.4: Others
  • 3.6: Global Neutralizing Antibody Market by End Use
    • 3.6.1: Hospitals and Clinics
    • 3.6.2: Research Institutes
    • 3.6.3: Diagnostic Laboratories
    • 3.6.4: Pharmaceutical Companies
    • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Neutralizing Antibody Market by Region
  • 4.2: North American Neutralizing Antibody Market
    • 4.2.1: North American Neutralizing Antibody Market by Application: Therapeutics, Diagnostics, Research and Development, and Others
    • 4.2.2: North American Neutralizing Antibody Market by End Use: Hospitals and Clinics, Research Institutes, Diagnostic Laboratories, Pharmaceutical Companies, and Others
  • 4.3: European Neutralizing Antibody Market
    • 4.3.1: European Neutralizing Antibody Market by Application: Therapeutics, Diagnostics, Research and Development, and Others
    • 4.3.2: European Neutralizing Antibody Market by End Use: Hospitals and Clinics, Research Institutes, Diagnostic Laboratories, Pharmaceutical Companies, and Others
  • 4.4: APAC Neutralizing Antibody Market
    • 4.4.1: APAC Neutralizing Antibody Market by Application: Therapeutics, Diagnostics, Research and Development, and Others
    • 4.4.2: APAC Neutralizing Antibody Market by End Use: Hospitals and Clinics, Research Institutes, Diagnostic Laboratories, Pharmaceutical Companies, and Others
  • 4.5: ROW Neutralizing Antibody Market
    • 4.5.1: ROW Neutralizing Antibody Market by Application: Therapeutics, Diagnostics, Research and Development, and Others
    • 4.5.2: ROW Neutralizing Antibody Market by End Use: Hospitals and Clinics, Research Institutes, Diagnostic Laboratories, Pharmaceutical Companies, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Neutralizing Antibody Market by Target Virus
    • 6.1.2: Growth Opportunities for the Global Neutralizing Antibody Market by Antibody Type
    • 6.1.3: Growth Opportunities for the Global Neutralizing Antibody Market by Application
    • 6.1.4: Growth Opportunities for the Global Neutralizing Antibody Market by End Use
    • 6.1.5: Growth Opportunities for the Global Neutralizing Antibody Market by Region
  • 6.2: Emerging Trends in the Global Neutralizing Antibody Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Neutralizing Antibody Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Neutralizing Antibody Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Regeneron Pharmaceuticals
  • 7.2: Eli Lilly and Company
  • 7.3: AstraZeneca
  • 7.4: GlaxoSmithKline
  • 7.5: Sanofi
  • 7.6: Roche
  • 7.7: Novartis
  • 7.8: Merck
  • 7.9: Pfizer
  • 7.10: Johnson & Johnson